Treatment guidelines difer signifcantly, not only between Europe and North America but also among European coun tries [1–4]. Reasons for these diferences include antimi crobial resistance patterns, accessibility to and reimburse ment policies for medicines, and culturally and historically determined …

ABSTRACT Purpose: Polypharmacy is a known risk factor for potentially inappropriate prescribing. Recently there is an increasing interest in clinical decision support systems (CDSS) to improve prescribing. The objective of this study was to evaluate the impact of a CDSS, with the START-STOPP criteria …

As the population ages, more people will have comorbid disorders and polypharmacy. Medication should be reviewed regularly in order to avoid adverse drug reactions and medication-related hospital visits, but this is often not done. As part of our student-run clinic project, we investigated whether an …